NBY Competitors & Alternatives
Compare NovaBay Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
NBY
Main Stock$1.95
Tradestie Score
43
Market Cap
$8.23M
Revenue Growth
-0.8%
Analyst Upside
-56.4%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 48 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 49 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.15
|
$67.94M | - | 58 | Compare |
|
SINT
SiNtx Technologies, Inc. Common Stock
|
$1.58
|
$11.23M | - | 46 | Compare |
|
SNGX
Soligenix, Inc. Common Stock
|
$0.37
|
$10.38M | - | 52 | Compare |
|
OGEN
Oragenics Inc.
|
$0.42
|
$5.86M | - | 48 | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
|
GHSI
GHSI
|
- | - | - | - | Compare |
More NBY Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry